Dr. Sai Yendamuri treats patients with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies using minimally invasive surgery. Dr. Yendamuri says that the complexity of malignant mesothelioma requires a multidisciplinary approach to treatment that includes coordination of chemotherapy, radiation therapy, and surgery that considers the needs of the individual patient. Dr. Yendamuri’s clinical expertise includes
Dr. Brendon M. Stiles is a thoracic surgeon who specializes in treating lung and esophageal cancers and unusual and rare thoracic cancers, including malignant pleural mesothelioma. He is the Chief of Thoracic Surgery and Surgical Oncology at Montefiore Einstein Comprehensive Cancer Center, as well as a Professor of Cardiothoracic Surgery and Associate Director of Surgical
Dr. Balazs Halmos is the Director of Thoracic Oncology, Director of Clinical Cancer Genomics, and Associate Director of Clinical Science at Montefiore Einstein Comprehensive Cancer Center. As one of three team leaders of the center’s lung cancer team, his clinical focus is on the management of patients with thoracic malignancies, including malignant pleural mesothelioma and
Dr. Benjamin Medina is a thoracic surgeon at the Rutgers Cancer Institute of New Jersey and RWJBarnabas Health. He specializes in thoracic malignancies including lung cancer and malignant pleural mesothelioma, as well as esophageal cancer, mediastinal tumors, and chest wall tumors, using robotic and minimally invasive techniques that minimize pain, shorten hospital stays, and provide
While malignant mesothelioma remains a fatal diagnosis, innovations in surgical techniques and other treatments have made a significant impact on overall survival and quality of life. A recent study conducted by researchers from Kaiser Permanente in Northern California confirmed that increased specialization of mesothelioma physicians and the use of bi-disciplinary tumor boards makes a significant
Dr. Konstantin H. Dragnev is a medical oncologist and renowned researcher at the Dartmouth Cancer Center. His principal clinical focus is on improving outcomes for patients diagnosed with non-small cell and small cell lung cancer, malignant pleural mesothelioma, and esophageal cancer using molecularly targeted therapies. Dr. Dragnev is also a professor of medicine at Dartmouth’s
Dr. Rian M. Hasson is a thoracic surgeon at the Dartmouth Cancer Center and Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire and Assistant Professor of Surgery at the Geisel School of Medicine at Dartmouth. She works as part of a multidisciplinary team to treat patients diagnosed with a range of thoracic cancers and benign diseases,
David J. Finley is the Program Director of Dartmouth Cancer Center’s Comprehensive Thoracic Oncology Program. A thoracic surgeon triple board certified in Surgery, General Surgery, and Thoracic and Cardiac Surgery, he is skilled in a wide range of surgical techniques. He specializes in the treatment of patients with malignant pleural mesothelioma, lung cancer, esophageal cancer,
Dr. Estelamari Rodriguez is a triple board-certified hematologist, oncologist, and internist at the University of Miami’s Sylvester Comprehensive Cancer Center. Her clinical interest is in the early detection and treatment of malignant mesothelioma and lung cancer, as well as in developing programs to eradicate disparities in health care. In addition to the care she provides
Dr. Apar Kishor Ganti is an oncologist and internal medicine specialist at the University of Nebraska Medical Center. He is a physician scientist whose primary interests are lung cancer, malignant pleural mesothelioma, thymoma, head and neck cancers, and thyroid cancers. Dr. Ganti is also an integral member of the Omaha VA Medical Center’s care team,